Chargement en cours...

Immunotherapy in Pediatric Acute Lymphoblastic Leukemia

The 5-year survival rate for children and adolescents with acute lymphoblastic leukemia (ALL) has improved to more than 90% in high-income countries. However, further increases in the intensity of conventional chemotherapy would be associated with significant adverse effects; therefore, novel approa...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Cancer Metastasis Rev
Auteurs principaux: Inaba, Hiroto, Pui, Ching-Hon
Format: Artigo
Langue:Inglês
Publié: 2019
Sujets:
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6995750/
https://ncbi.nlm.nih.gov/pubmed/31811553
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10555-019-09834-0
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!